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Preface 
R egularly distributed throughout the human integu­ment are more than 20 billion pigment cells. The pigment cell is a unicellular secretory gland having the specialized functions of synthesizing and secreting melanin granules through their cytoplasmic den­
drites. 
UP. until a decade ago our biochemical and molecular under­
standing pf melanogenesis was rather straightforward. The melanin 
granules were simply considered to be synthesized by two factors: 
tyrosinase and melanosomes. Thus a major effort of pigment cell 
research has been focused on the further clarification of these factors 
in normal and abnormal pigment cells. But this concept, as briefly 
introduced below, has been gready expanded, resulting in a renais­
sance in the pigment cell scientific community. 
In this supplement to TheJournal of Investigative Dermatology, the 
most up-to-date, current progress is thus collected in the hOIJe that 
the new information obtained by diverse fields of scientific en­
deavor will provide valuable examples, not only to pigment cell 
researchers, but also to all scientists interested in skin and its aberra­
tions. 
Pigment cells are unique among cells, not only in the integument 
but among all mammalian cells, being highly specialized protein 
synthesizing cells. They possess all the necessary cellular equip­
ment, thereby providing a good prototype target for study of the 
theoretical and practical control of elementary cell function. For a 
wide variety of reasons -from its significant function as the pro­
ducer of melanin polymer to studies of racial diversity in skin, hair, 
and eye color, to the crucial need to combat melanoma-the 
pigment cell attracts the attention of a wide spectrum of multi­
aisciplined scientists: embryologists, geneticists, chemists, endocri­
nologists, physiologists, biophysicists, biochemists, pathologists, 
molecular biologists, and medical scientists. 
Brought together here is the current state of knowledge of the 
cellular and molecular biology of melanocyte proliferation and mel­
anogenesis, along with some perspectives on how these are applied 
in melanoma research. Current research on melanocyte biology and 
control is presented from many different viewpoints, including the 
molecular genetics of tyrosinase, melanosomal structure, factors 
controlling melanization, the chemistry of melanin, melanocyte 
responses to growth factors, cytokines and inflammatory mediators, 
and cellular alterations in the process of melanoma genesis and 
progression. 
Beyond the Melanosomal Era Research on pigment cells over 
the last decade has yielded many discoveries. It has now been shown 
in pigment cells that, besides melanosome organelles, non-melano­
somal melanogenic sub-cellular compartments, such as the GERL­
coated vesicles, play a critical role in the glycosylation and transport 
of tyrosinases into pre-melanosomes. Furthermore, melanin mono­
mers are also found to be already rich within coated vesicles prior to 
their fusion to melanosomes. Concerning melanogenesis-control­
ling enzymes, in the last few years it has been found that not only 
tyrosinase, but also dopachrome tautomerase. catechol-O-methyl­
transferase, y-glutamyl-transpeptidase, and peroxidase, are critically 
involved in mixed melanogenesis. 
Era of Gene Analysis and Control Rapid advances in gene 
research in recent years have yielded many discoveries allowing us 
to more fully understand genes that control mammalian melanogen­
esis and pigmentation. Now in mice, more than 150 mutations 
affecting pigmentation have been identified at more than 50 gene 
loci. Many of these genes critical to pigmentation have been cloned, 
sequenced, and mapped and most of them show similar expression 
in humans as they do in mice. 
Revision of Melanocyte Concept Melanocytes were once 
thought to be primarily involved in protection of the epidermis 
from the damaging effects ofUV radiation. However, they are now 
thought to participate more in the inflammatory response through a 
variety of chemical mediators and have recendy been seen to be a 
source of and responsive to most chemical mediators of inflamma­
tion. 
Melanoma Control and Eradication Deeper understanding of 
malignant melanoma oncogenesis particularly through oncogenes 
and suppressor oncogenes, and melanoma growth control through 
interferons, cytokines, and selective thermal neutron therapy using 
melanoma-seeking lOB-compounds has been proceeding at a re­
markable pace, thus facilitating progress in control and eradication 
in one of the most formidable malignancies in man. 
While organizing the XNth International Pigment Cell Confer­
ence (Mishima Y (ed.): The Pigment Cell: From the Molecular to 
the Clinical Level. Munksgaard, Copenhagen, 1992, pp 1-312), in 
Kobe, 1990 it was felt that the rapid and diverse advancement in 
pigment research was so huge that a separate satellite meeting, pro­
viding more detailed and provocative discussion, could be offered. 
This satellite meeting, "The International Symposium on Pigment 
Cell Control: Epigenetic and Genetic Regulation of Skin Pigmen­
tation," was held as the Hayashibara Forum in Okayama, Japan, on 
November 5-7,1990, and brought together some of the leading 
pigment cell researchers from the US, Japan, and Europe to gather 
and informally discuss the latest scientific events in the field. 
From the seeds sown at the Symposium, we have witnessed fur­
ther maturation of the evidence and development of newer con­
cepts. We decided that this was the prime time to publish this 
special supplement to The Journal oj Investigative Dermatology. 
Both the forum and this supplement were made possible through 
the assistance of a grant from the Hayashibara Foundation, and this 
supplement is also supported in part by The Journal of Investigative 
Dermatology. We would like to express our sincere appreciation to 
Mr. Ken Hayashibara, Chairman, Board of Trustees of the Founda­
tion, for his generous support. 
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